Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "ESKD, Major Cardiovascular Events, and Death Associated With Systemic Inflammation" [<i>Kidney International Reports</i> Volume 11, Issue 4, April 2026, 106364].

Kidney international reports·2026
Same author

French Translation and Psychometric Evaluation of the Standardized Outcomes in Nephrology Life Participation Instrument Among Kidney Transplant Recipients.

Kidney international reports·2026
Same author

Uremic Toxins and the Lung Alveolar Capillary Barrier: A Narrative Review.

Toxins·2026
Same author

Reversible cerebral lesions in adult STEC-associated hemolytic uremic syndrome.

Kidney international·2026
Same author

ESKD, Major Cardiovascular Events, and Death Associated With Systemic Inflammation.

Kidney international reports·2026
Same author

Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis.

European journal of internal medicine·2026

Related Experiment Video

Updated: Dec 25, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K

Rituximab-associated neuropathy: About two cases

Valentin Maisons1, Saleh Kaysi2

  • 1CHR Orléans, 14 Avenue de l'Hôpital, F-45100, Orléans, France; UFR Médecine Tours, 10 boulevard Tonnellé, F-37000, Tours, France.

European Journal of Internal Medicine
|March 21, 2020
PubMed
Summary

No abstract available in PubMed .

Keywords:
Adverse effectsCase reportsRituximab

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.9K
Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons
09:27

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Published on: October 10, 2025

363

Related Experiment Videos

Last Updated: Dec 25, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.9K
Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons
09:27

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Published on: October 10, 2025

363